Education
About Us
Working with TipRanks
Follow Us
DiaSorin S.p.A. (IT:DIA)
:DIA
DIA Stock Chart & Stats
Day’s Range― - ―
52-Week Range€81.88 - €112.35
Previous CloseN/A
Volume135.55K
Average Volume (3M)252.23K
Market Cap
€4.95B
Enterprise Value€5.57B
Total Cash (Recent Filing)€0.00
Total Debt (Recent Filing)€672.00M
Price to Earnings (P/E)24.3
Beta0.48
Next Earnings
Nov 05, 2025EPS Estimate
1.01Last Dividend Ex-Date
May 19, 2025Dividend Yield1.33%
Share Statistics
EPS (TTM)1.12
Shares Outstanding55,948,257
10 Day Avg. Volume379,902
30 Day Avg. Volume252,233
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€98.77Price Target Upside15.95% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
Bulls Say, Bears Say
Bulls Say
Financial PerformanceDiaSorin reported 4Q results which were a slight beat vs Consensus on Topline and EBITDA, starting the year on a solid footing backdrop considered.
Growth ProspectsManagement also pointed to ~25% combined yoy growth for the Verigene and LIAISON PLEX to around €75m, which implies low-teens growth for FY25 in Molecular Diagnostics for FY25, which serves as a solid departure point into FY25.
Bears Say
Geographical PerformanceEuropean growth slowed to 4% CER, with US growing 15%, effectively normalising above average growth driven by high market share tests.
DiaSorin S.p.A. News
DIA FAQ
What was DiaSorin S.p.A.’s price range in the past 12 months?
DiaSorin S.p.A. lowest stock price was €81.88 and its highest was €112.35 in the past 12 months.
What is DiaSorin S.p.A.’s market cap?
DiaSorin S.p.A.’s market cap is €4.95B.
When is DiaSorin S.p.A.’s upcoming earnings report date?
DiaSorin S.p.A.’s upcoming earnings report date is Nov 05, 2025 which is in 68 days.
How were DiaSorin S.p.A.’s earnings last quarter?
DiaSorin S.p.A. released its earnings results on Jul 31, 2025. The company reported €1.124 earnings per share for the quarter, beating the consensus estimate of €1.119 by €0.005.
Is DiaSorin S.p.A. overvalued?
According to Wall Street analysts DiaSorin S.p.A.’s price is currently Undervalued.
Does DiaSorin S.p.A. pay dividends?
DiaSorin S.p.A. pays a Annually dividend of €1.2 which represents an annual dividend yield of 1.33%. See more information on DiaSorin S.p.A. dividends here
What is DiaSorin S.p.A.’s EPS estimate?
DiaSorin S.p.A.’s EPS estimate is 1.01.
How many shares outstanding does DiaSorin S.p.A. have?
DiaSorin S.p.A. has 55,948,257 shares outstanding.
What happened to DiaSorin S.p.A.’s price movement after its last earnings report?
DiaSorin S.p.A. reported an EPS of €1.124 in its last earnings report, beating expectations of €1.119. Following the earnings report the stock price went down -2.768%.
Which hedge fund is a major shareholder of DiaSorin S.p.A.?
Currently, no hedge funds are holding shares in IT:DIA
Company Description
DiaSorin S.p.A.
DiaSorin S.p.A. develops, manufactures, and distributes immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIAISON XL, and LIAISON XL LAS; and molecular diagnostics platform comprising of LIAISON MDX for use in the amplification of nucleic acids to diagnose viral infections through the identification of virus in patient's biological sample. It has partnership agreements with QIAGEN for diagnostic solution for Latent Tuberculosis detection; TTP for the development of molecular Point-of-Care solution; and MeMed for the launch of a test differentiating between viral and bacterial infections. The company was founded in 1968 and is headquartered in Saluggia, Italy.
DIA Stock 12 Month Forecast
Average Price Target
€98.77
▲(15.95% Upside)
Technical Analysis
Recordati Industria Chimica e Farmaceutica SPA
―
PharmaNutra SpA
―
Garofalo Health Care S.P.A.
―
GPI SpA
―
Svas Biosana S.p.A.
―
Ownership Overview
12.49% Insiders
6.40%
Mutual Funds
― Other Institutional Investors
77.04% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---